Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Capital Fund is an early-stage venture capital fund managed by ID Ventures, the venture investment arm of Invest Detroit. The fund was created to provide milestone-based pre-seed and seed capital to high-tech startups in Michigan, with the goal of helping companies reach follow-on financing. It is not itself a biotechnology, pharmaceutical, or healthcare operating company, though it may invest in companies across sectors including life sciences. Publicly available sources indicate it has been active since 2017 and has invested in startups such as Opus Genetics, formerly Ocuphire Pharma. The entity is best characterized as an investment fund rather than a therapeutic developer or healthcare services company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Capital Fund.